CordenPharma's Strategic Acquisition of AmbioPharm Expands Peptide API Capacity
CordenPharma's acquisition of AmbioPharm expands its global peptide API manufacturing capabilities, presenting new opportunities for AECM businesses in pharmaceutical construction and compliance.